Amgen Inc.Equity-NMS: AMGN
Equity-NMS: AMGN
$300.19
-5.66
(28 May)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$300.19
Open
$300.19
Today’s high
$303.50
Today’s low
$298.31
52W low
$211.71
52W high
$329.72
1Y
42.29%
5Y
15.63%
PE
43.60
Div yield
2.80%
EPS (TTM)
7.00
Dividend
8.57
Shares O/S
536.43M
Market cap
161.03B
Insights
AMGN price is above its 200 day moving average
AMGN PE is in the highest 10% across all stocks. The market is valuing it as a growth stock on an earnings basis.
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About Amgen Inc.

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and improve people's lives. It operates in human therapeutics segment. The Company’s marketed products portfolio includes Aranesp, ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin alfa), KYPROLIS, Repatha (evolocumab), Nplate (romiplostim), Vectibix (panitumumab), MVASI (bevacizumab-awwb), Parsabiv (etelcalcetide), EPOGEN (epoetin alfa), KANJINTI (trastuzumab-anns), BLINCYTO (blinatumomab), Aimovig (erenumab-aooe), EVENITY (romosozumab-aqqg), AMGEVITATM (adalimumab), Sensipar/Mimpara (cinacalcet), NEUPOGEN (filgrastim), IMLYGIC (talimogene laherparepvec), Corlanor (ivabradine), KYPROLIS (carfilzomib), Maridebart cafraglutide, (infliximab-axxq), Evenity, LumaKras, Nplate and XGeva, others.

.


FAQs

Can I buy Amgen Inc. shares in India?
How to buy Amgen Inc. shares in India?
What is the share price of Amgen Inc.?
What is the Market Capitalization of Amgen Inc.?
What is the PE ratio of Amgen Inc.?
Is Amgen Inc. a good stock to buy?
In which sector / industry does Amgen Inc. operate?